Create Free Account

By creating account you will get access to hot stocks & personalised emails

Ebr Systems Inc CDR

Healthcare AU EBR

1.03AUD
0.01(1.48%)

Last update at 2024-11-13T05:10:00Z

Day Range

0.981.04
LowHigh

52 Week Range

0.541.24
LowHigh

Fundamentals

  • Previous Close 1.01
  • Market Cap363.58M
  • Volume248729
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-37.51896M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.2

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -33.08660M -39.83537M -26.41608M -24.81276M
Minority interest - - - -
Net income -33.08821M -39.83537M -25.71833M -24.81276M
Selling general administrative 5.41M 3.14M 12.57M 8.56M
Selling and marketing expenses 8.11M 6.81M - -
Gross profit - - - -5.77996M
Reconciled depreciation 0.65M 0.38M - -
Ebit -24.27712M -15.24084M -20.58094M -25.38837M
Ebitda -23.62468M -14.85682M - -
Depreciation and amortization 0.65M 0.38M - -
Non operating income net other - - - -
Operating income -24.27712M -15.24084M -20.58094M -23.83453M
Other operating expenses 27.39M 17.57M - -
Interest expense 1.53M 19.01M 0.00000M 0.00000M
Tax provision 0.00160M 0.00000M -0.69775M 0.00000M
Interest income 2.46M 0.02M 6.46M 0.98M
Net interest income 0.94M -18.99105M - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.00160M 20.94M -0.69775M -
Total revenue - 0.00000M 0.00000M 1.29M
Total operating expenses 27.39M 17.57M - -
Cost of revenue - - - 7.07M
Total other income expense net -7.28321M -3.65871M - -
Discontinued operations - - - -
Net income from continuing ops -33.08821M -39.83537M - -
Net income applicable to common shares -33.08821M -39.83537M -25.71833M -24.81276M
Preferred stock and other adjustments - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 78.90M 71.68M 85.42M 8.40M 12.39M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.38M 0.61M 0.17M 0.07M 0.84M
Total liab 47.84M 27.73M 9.53M 46.05M 26.21M
Total stockholder equity 31.06M 43.95M 75.90M -37.65058M -13.82573M
Deferred long term liab - - - - -
Other current liab 4.32M 3.57M 3.01M - -
Common stock - 320.78M 319.41M 0.00132M 0.00131M
Capital stock 342.75M 320.78M 319.41M - -
Retained earnings -311.69613M -276.82768M -243.50751M -203.85144M -178.13311M
Other liab - 0.48M - 7.15M 3.13M
Good will - - - - -
Other assets - 0.59M 0.44M 0.44M 0.15M
Cash 14.58M 15.46M 78.24M 5.88M 7.29M
Cash and equivalents - 15.46M 78.24M 5.88M 7.29M
Total current liabilities 6.45M 5.93M 7.32M 27.32M 5.62M
Current deferred revenue - - 0.00000M - -
Net debt 25.09M 6.13M -73.43513M - -
Short term debt - 0.27M 2.60M 0.00000M 0.00000M
Short long term debt 0.02M 0.05M 2.41M - -
Short long term debt total - 21.59M 4.81M - -
Other stockholder equity - 0.79M 1.03M -0.08784M -
Property plant equipment - 3.52M 3.89M 0.89M 0.87M
Total current assets 74.37M 66.59M 81.10M 7.07M 11.37M
Long term investments 1.13M 0.99M - - -
Net tangible assets - 43.95M 75.90M -37.65906M -13.83421M
Short term investments 57.74M 48.07M - - -
Net receivables 0.24M 0.44M 0.97M 0.27M 0.17M
Long term debt 39.65M 19.40M 0.07M 11.55M 17.47M
Inventory - 2.00M 1.72M - 2.84M
Accounts payable 1.86M 2.09M 1.71M 0.90M 4.62M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.59M 0.59M 0.44M - -
Deferred long term asset charges - - - - -
Non current assets total 4.52M 5.09M 4.32M - -
Capital lease obligations 1.92M 2.14M 2.32M - -
Long term debt total - 19.40M 0.07M 11.55M 17.47M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -49.34781M -0.90681M -48.61763M -48.61763M
Change to liabilities 0.73M 0.72M -0.47901M 1.50M
Total cashflows from investing activities -49.34781M -0.90681M -0.26530M -0.24213M
Net borrowings 17.60M 20.02M 16.50M 11.40M
Total cash from financing activities 17.01M 95.76M 16.41M 11.28M
Change to operating activities 0.42M 0.39M 1.53M 0.26M
Net income -33.08821M -39.83537M -25.71833M -24.81276M
Change in cash -62.78600M 72.36M -1.40722M -10.02256M
Begin period cash flow 78.24M 5.88M - -
End period cash flow 15.46M 78.24M 5.88M -
Total cash from operating activities -30.35592M -22.14939M -17.54706M -21.05749M
Issuance of capital stock 0.42M 80.93M - -
Depreciation 0.65M 0.38M 0.25M 0.21M
Other cashflows from investing activities -48.61763M 0.00520M - -
Dividends paid -20.00000M -22.42455M - -
Change to inventory - - 2.84M 1.46M
Change to account receivables - - - 0.51M
Sale purchase of stock -0.21333M -4.90158M 0.01M 0.03M
Other cashflows from financing activities 19.21M 22.13M -0.10752M -0.15152M
Change to netincome 0.31M -0.70866M -0.98268M -0.18598M
Capital expenditures 0.73M 0.91M 0.27M 0.24M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 1.15M 1.11M 3.89M 3.73M
Stock based compensation - - - -
Other non cash items - - - -
Free cash flow -0.73018M -0.91201M - -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EBR
Ebr Systems Inc CDR		 0.01 1.48% 1.03 - - - 21.41 - -3.6785
COH
Cochlear Ltd		 -2.48 0.83% 296.93 53.21 47.17 8.48 10.35 8.40 32.43
PNV
Polynovo Ltd		 - -% 2.06 208.00 135.14 13.92 19.54 13.36 340.64
AVH
Avita Therapeutics Inc		 0.14 3.80% 3.82 - - 8.76 12.74 5.31 -10.0538
AVR
Anteris Technologies Ltd		 -0.81 8.17% 9.10 - - 56.55 37.96 53.38 -5.1986

Reports Covered

Stock Research & News

View All

Profile

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning. EBR Systems, Inc. was incorporated in 2003 and is based in Sunnyvale, California.

Ebr Systems Inc CDR

480 Oakmead Parkway, Sunnyvale, CA, United States, 94085

Key Executives

Name Title Year Born
Mr. Allan R. Will Exec. Chairman 1954
Mr. John G. McCutcheon Pres, CEO & Director 1961
Mr. Frank Hettmann Chief Financial Officer NA
Mr. Michael Hendricksen Chief Operating Officer NA
Dr. N. Parker Willis Ph.D. Chief Technical Officer NA
Mr. Andrew Shute Sr. VP of Global Field Operations NA
Ms. Madhuri Bhat Chief Regulatory Officer NA
Dr. Spencer H. Kubo M.D. Chief Medical Officer NA
Mr. Steve Sandweg Chief Commercial Officer NA
Mr. John H. Sellers Sec. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.